WST Stock: Price, Earnings History and SEC Filings
West Pharmaceutical Services, Inc. (WST) last traded at $412.62, down 0.97% on the latest session and up 11.3% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $2.66 against an analyst estimate of $2.18, a beat of 22.0%.
$412.62 -0.97%
1 month+11.29%
52-week high$438.27
52-week low$223.83
Volume1.06M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
WST earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 29, 2026 | $2.66 | $2.18 | +22.02% |
| Jun 2026 | Jul 23, 2026 | $2.37 | $2.08 | +13.94% |
| Mar 2026 | Apr 23, 2026 | $2.13 | $1.68 | +26.79% |
| Dec 2025 | Feb 12, 2026 | $2.04 | $1.83 | +11.48% |
WST beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for WST
SEC filing data is not available right now. You can search for WST on SEC EDGAR.
WST news
- How Investors Are Reacting To West (WST) Earnings BeatNov 1, 2026 · finance.yahoo.com
- West Pharmaceutical Services (WST) Lifted Its Outlook, Is The Stock Fully Priced?Nov 1, 2026 · finance.yahoo.com
- WST Q3 deep dive: Biologics and regulatory tailwinds fuel margin expansion, HVP mix shift continuesNov 1, 2026 · finance.yahoo.com
- What West Pharmaceutical Services (WST) Said on Its Q3 Earnings CallOct 31, 2026 · marketbeat.com
- West Pharmaceutical Services, Inc. Q3 2026 Earnings Call SummaryOct 29, 2026 · app.moby.co
- West (WST) Q3 2026 Earnings Call TranscriptOct 29, 2026 · fool.com
- West Pharma Q3 Earnings Rise on HVP Strength, 2026 Outlook RaisedOct 29, 2026 · finance.yahoo.com
- Compared to Estimates, West Pharmaceutical (WST) Q3 Earnings: A Look at Key MetricsOct 29, 2026 · finance.yahoo.com
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) is a US-listed public company on NYSE.